A Phase 1 Study of Sunitinib Malate [sunitinib] in Combination With Cisplatin/Capecitabine or Oxaliplatin/Capecitabine in Patients With Advanced Gastric Cancer.
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2013
At a glance
- Drugs Capecitabine; Cisplatin; Oxaliplatin; Sunitinib
- Indications Gastric cancer
- Focus Adverse reactions
- 27 Dec 2011 Actual end date Dec 2011 added as reported by ClinicalTrials.gov.
- 27 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Nov 2011 Planned end date changed from 1 Oct 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.